Q1FY27 results: Revenue up 31%, PAT jumps 135% YoY (standalone)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.7 pts less than Nifty Microcap 250 and 10.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemcrux Enterprises posted Q1FY27 (quarter ended 30 June 2026) standalone revenue of Rs 21.94 crores, up 31% YoY from Rs 16.75 crores. Standalone PAT surged to Rs 1.37 crores from Rs 58.45 lakhs, up about 135%. On a consolidated basis with subsidiary Kalichem, PAT rose to Rs 50.52 lakhs from Rs 5.27 lakhs. EPS stood at Rs 0.93 versus Rs 0.39. Board granted 1,07,700 ESOPs at Rs 10 per share. Clean limited review report from auditors.
Strong revenue and profit growth on a low base; ESOPs may cause mild future dilution. Clean audit report is positive.